A randomized, double-blind, placebo-controlled, multicenter, long-term trial of preventing hypertension using candesartan cilexetil 16mg in patients with high normal blood pressure (TROPHY)
Latest Information Update: 19 Sep 2017
Price :
$35 *
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TROPHY
- Sponsors AstraZeneca
- 29 Aug 2011 Actual end date changed from Jun 2005 to Oct 2005 as reported by ClinicalTrials.gov.
- 21 Jun 2010 Results presented at the 20th European Meeting on Hypertension
- 14 Nov 2005 New trial record.